XML 82 R66.htm IDEA: XBRL DOCUMENT

Earnings per share (Tables)

12 Months Ended

Jun. 30, 2023

Text block [abstract]

Summary of earnings per share


		2023 A$’000				2022 restated A$’000				2021 restated A$’000

Earnings per share for loss from continuing operations


Loss after income tax attributable to the owners of Kazia Therapeutics Limited			(20,465	)			(25,014	)			(8,420	)

Loss after income tax attributable to the owners of Kazia Therapeutics Limited			(20,465	)			(25,014	)			(8,420	)


		Number				Number				Number

Weighted average number of ordinary shares used in calculating basic earnings per share			184,284,350				132,467,686				117,674,543

Weighted average number of ordinary shares used in calculating diluted earnings per share			184,284,350				132,467,686				117,674,543


		Cents				Cents				Cents

Basic earnings per share			(11.23	)			(18.88	)			(7.16	)
Diluted earnings per share			(11.23	)			(18.88	)			(7.16	)